Home | Welcome to Contract Pharma   
Last Updated Friday, September 19 2014
Print

Breaking News

Related Searches: CRO Clinical Trials Phase III Development
May 8, 2012
Will co-promote wet AMD drug in Japan  Read More »
May 7, 2012
Trial shows lack of clinically meaningful efficacy  Read More »
May 7, 2012
CRO Anticipates significant growth in the region  Read More »
May 7, 2012
Enhances global services with Harrogate pickup  Read More »
May 7, 2012
Partnership establishes product supply in China  Read More »
May 7, 2012
Jubilant LifeSciences 4Q Revenues: $216.2 million 4Q Loss: $11.7 million FY Revenues: $786.7 million FY Earnings: $2.8 million Comments: CMO operations, including the Jubilant HollisterStier operations, were up 17% year-on-year to $114 million i…  Read More »
May 4, 2012
Struik responsible for business development efforts throughout the region  Read More »
May 4, 2012
Warning letter specified nine items  Read More »
May 4, 2012
Customized endonuclease now available through Sartorius  Read More »
May 4, 2012
Five-year contract valued at $10 million  Read More »
May 4, 2012
New center will be devoted to hot melt extrusion research   Read More »
Gil Roth
May 3, 2012
Early Development slowdown leads to restructuring  Read More »
Gil Roth
May 3, 2012
Fill/finish line in Ireland to double Myozyme, Lumizyme capacity  Read More »
Gil Roth
May 3, 2012
Klitgaard, to take CIO role  Read More »
Gil Roth
May 3, 2012
Preclinical revenues drop, offset by RMS uptick  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On